Penumbra, Inc. PEN
320.62 USD -0.29 (-0.09%)
Regular-session close
320.62 0.00 0.00%
After hours · Nov 16, 4:00 PM ET
320.06 Day range 321.99
276.01 52-week range 362.41
- YTD
- +3.12%
- 1 year
- +14.48%
Benzinga news
benzinga.com Penumbra Q3 EPS $1.07 Misses $1.25 Estimate, Sales $410.145M Beat $403.345M Estimate Penumbra (NYSE:PEN) reported quarterly earnings of $1.07 per share which missed the analyst consensus estimate of $1.25 by 14.4 percent. This is a 10.31 percent increase over earnings of $0.97 per…
benzinga.com Penumbra Wins FDA Clearance For Lightning CAVT Technology To Treat Deep Vein Thrombosis, Backed By BOLT-DVT Trial Results BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial, demonstrated first-line use of computer assisted vacuum thrombectomy (CAVT) for DVT is safe and…
